Electrodiagnostic criteria for diagnosis of ALS.

By M. de Carvalho, R. Dengler, A. Eisen, J. England, R. Kaji, J. Kimura, K. Mills, H. Mitsumoto, H. Nodera, J. Shefner and 1 more. Clinical Neurophysiology, 2008

1,170 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Neurology

View Paper: https://www.semanticscholar.org/paper/fad4193616580226a8ba7fdfef8f6cf4f1b30615

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Zarei
2. K. Carr
3. L. Reiley
4. M. Strong
5. K. Díaz
6. Orleiquis Guerra
7. A. Roberts-South
8. W. Pagani

Citations in the corpus

• A comprehensive review of amyotrophic lateral sclerosis (2015, methodology): “[65] ALS is primarily a clinically diagnosed disease based on the exclusion of other causes of progressive UMN and LMN dysfunction.[65,115] There are standard criteria and diagnostic tests that help rule out many of the differential diagnosis of ALS.”
• Amyotrophic lateral sclerosis: a clinical review (2020, neutral): “Most clinicians do not rely on the available revised El Escorial criteria [8] or the Awaji algorithm [9], as these criteria lack sensitivity, rather capturing disease”
• Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria (2017, background): “It is recommended that patients diagnosed with ALS should fulfil either the El Escorial criteria (revised) or the Awaji criteria (revised).”